The Clinical Characteristics and Prognostic Nomogram for Head and Neck Cancer Patients with Bone Metastasis

Figure 5

DCA of the prognostic nomogram for the survival prediction of HNC patients with bone metastasis. (a) 12-month survival benefit in the training group. (b) 24-month survival benefit in the training group. (c) 36-month survival benefit in the training group. (d) 12-month survival benefit in the validation group. (e) 24-month survival benefit in the validation group. (f) 36-month survival benefit in the validation group.

(a)

(b)

(c)

(d)

(e)

(f)